Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 28, 2015
[Three cases of long-term control of non-small-cell lung cancer via S-1 monotherapy in elderly patients]Takeshi Numata, Hajime Osawa, Yuki Homma, et al.Internal Medicine (Tokyo, Japan)|November 3, 2017
Seasonal Influenza Vaccine-induced Pneumonitis Presenting with Multiple Pulmonary NodulesTakeshi Numata, Norihito Hida, Kai Yazaki, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2014
Epidermal growth factor receptor mutations: effect on volume doubling time of non-small-cell lung cancer patientsRyota Nakamura, Yoshihisa Inage, Rika Tobita, et al.Anticancer Research|May 31, 2022
Effect of Postoperative Muscle Loss After Resection of Non-small Cell Lung Cancer on Surgical OutcomesRyota Nakamura, Satoshi Yoneyama, Rika Tobita, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 12, 2018
Sarcopenia in Resected NSCLC: Effect on Postoperative OutcomesRyota Nakamura, Yoshihisa Inage, Rika Tobita, et al.Anticancer Research|February 2, 2024
Prognostic Impact of Preoperative Assessment of Muscle Mass and Strength in Surgically Resected Lung CancerShusuke Kurihara, Ryota Nakamura, Satoshi Yoneyama, et al.International Journal of Cancer|October 27, 2025
Prospective validation study of nutritional and immunological predictors in immune checkpoint inhibitor efficacy for non-small cell lung cancerShinkichi Takamori, Mototsugu Shimokawa, Masafumi Yamaguchi, et al.Investigational New Drugs|January 9, 2025
Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNAYoshihiko Taniguchi, Akihiro Tamiya, Mitsuo Osuga, et al.BMC Pulmonary Medicine|August 24, 2024
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance statusYoshihiko Taniguchi, Akihiro Tamiya, Mitsuo Osuga, et al.Cancer Medicine|April 5, 2025
Circulating Tumour DNA in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer and Early Disease Progression After First-Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational StudyAkihiro Tamiya, Yasuyuki Mizumori, Mitsuo Osuga, et al.Pageof 2